Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» gene therapy
gene therapy
Former AveXis executives launch gene therapy startup with uncommon targets
Former AveXis executives launch gene therapy startup with uncommon targets
BioPharma Dive
biotech
startups
AveXis
Zolgensma
gene therapy
Jaguar Gene Therapy
Flag link:
Precision's one-time gene editing treatment lowers cholesterol in monkeys for 3 years
Precision's one-time gene editing treatment lowers cholesterol in monkeys for 3 years
Fierce Biotech
Precision Biosciences
gene therapy
gene editing
familial hypercholesterolemia
Flag link:
Bluebird’s Zynteglo safety snag could spell trouble for other gene therapies: analysts
Bluebird’s Zynteglo safety snag could spell trouble for other gene therapies: analysts
Fierce Pharma
gene therapy
Bluebird Bio
Zynteglo
clinical trials
Flag link:
Charles River Dives Deep Into Cell and Gene Therapy With Cognate BioServices Acquisition
Charles River Dives Deep Into Cell and Gene Therapy With Cognate BioServices Acquisition
BioSpace
Charles River Labs
Cognate BioServices
gene therapy
CDMOs
M&A
Flag link:
Novartis and the Gates Foundation aim to create a more practical gene therapy for sickle cell patients around the world
Novartis and the Gates Foundation aim to create a more practical gene therapy for sickle cell patients around the world
Stat
Novartis
Gates Foundation
gene therapy
sickle cell disease
Flag link:
Bluebird stops studies of sickle cell gene therapy after new cancer cases
Bluebird stops studies of sickle cell gene therapy after new cancer cases
BioPharma Dive
Bluebird Bio
gene therapy
sickle cell disease
leukemia
clinical trials
Flag link:
A gene therapy pipeline takes shape for a cluster of rare diseases
A gene therapy pipeline takes shape for a cluster of rare diseases
BioPharma Dive
gene therapy
Fabry disease
Avrobio
Flag link:
Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors
Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors
Fierce Biotech
George Church
gene therapy
adenovirus
Flag link:
Bayer’s gene therapy juggling act
Bayer’s gene therapy juggling act
EP Vantage
Bayer
gene therapy
AskBio
Flag link:
Avrobio gene therapy eliminates toxic substrate in Fabry patient
Avrobio gene therapy eliminates toxic substrate in Fabry patient
Fierce Biotech
Avrobio
gene therapy
Fabry disease
clinical trials
Flag link:
The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic
The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic
Endpoints
Vertex Pharmaceuticals
Semma Therapeutics
M&A
gene therapy
VX-880
type 1 diabetes
Flag link:
Gene therapy for hemophilia: So close, yet so far away
Gene therapy for hemophilia: So close, yet so far away
BioPharma Dive
hemophilia
hemophilia A
hemophilia B
gene therapy
Biomarin
uniQure
Flag link:
How 2 scientific pioneers teamed up to run AskBio, Bayer's new gene therapy division
How 2 scientific pioneers teamed up to run AskBio, Bayer's new gene therapy division
BioPharma Dive
Bayer
AskBio
M&A
gene therapy
Flag link:
Rexgenero renamed Ixaka after integration of nanoparticle tech business and funding boost
Rexgenero renamed Ixaka after integration of nanoparticle tech business and funding boost
Biopharma Reporter
Rexgenero
cell therapy
Ixaka
nanoparticles
gene therapy
Flag link:
Thermo Fisher Takes Deep Dive into Cell and Gene Therapy with Viral Vector Business Buy
Thermo Fisher Takes Deep Dive into Cell and Gene Therapy with Viral Vector Business Buy
BioSpace
Thermo Fisher
cell therapy
gene therapy
viral vector
Henogen AS
Flag link:
BioMarin tries to get hemophilia gene therapy back on track with positive data
BioMarin tries to get hemophilia gene therapy back on track with positive data
BioPharma Dive
Biomarin
hemophilia A
gene therapy
clinical trials
Roctavian
Flag link:
Pfizer beats Sarepta to the start of first late-stage Duchenne gene therapy trial
Pfizer beats Sarepta to the start of first late-stage Duchenne gene therapy trial
BioPharma Dive
Pfizer
Sarepta Therapeutics
clinical trials
Duchenne Muscular Dystrophy
gene therapy
Flag link:
Biotech Bayer's VC arm leads $105M round for 'gene circuit' startup Senti Bio
Biotech Bayer's VC arm leads $105M round for 'gene circuit' startup Senti Bio
Fierce Biotech
Bayer
venture capital
gene therapy
Senti Biosciences
Flag link:
Fujifilm's CDMO carves foothold in Boston biotech hub with new HQ focused on viral vectors, gene therapies
Fujifilm's CDMO carves foothold in Boston biotech hub with new HQ focused on viral vectors, gene therapies
Endpoints
Fujifilm
Fujifilm Diosynth Biotechnologies
CDMOs
Boston
gene therapy
vaccines
Flag link:
Audentes sees FDA hold lifted after 3 trial deaths blighted $3B program
Audentes sees FDA hold lifted after 3 trial deaths blighted $3B program
Fierce Biotech
Audentes
Astellas
FDA
clinical trials
AT132
gene therapy
X-linked myotubular myopathy
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »